IPP Bureau
US govt signs deal with GSK and Vir Biotechnology to buy sotrovimab, a Covid-19 treatment
By IPP Bureau - November 18, 2021
The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease
AstraZeneca’s Covid-19 drug offers 83% protection over six months
By IPP Bureau - November 18, 2021
Six-months follow-up of prevention trial showed 83% reduced risk of symptomatic Covid-19, with no severe disease or deaths
Sluggish exports to cap pharma revenue growth at 9% this fiscal
By IPP Bureau - November 17, 2021
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
Private equity firm Carlyle partners with Viyash Life Sciences for pharma platform
By IPP Bureau - November 17, 2021
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
Pfizer seeks EUA from U.S. FDA for Covid-19 drug
By IPP Bureau - November 17, 2021
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
Biocon Biologics and Viatris announce US launch of Semglee
By IPP Bureau - November 17, 2021
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
PM to inaugurate first Global Innovation Summit of Pharmaceuticals sector
By IPP Bureau - November 17, 2021
The Summit will also witness participation of Union Minister of Health & Family Welfare and Chemicals & Fertilizers Dr. Mansukh Mandaviya
Cipla launches Spirofy for early diagnosis of COPD
By IPP Bureau - November 17, 2021
It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)
World’s first Donepezil patch to treat Alzheimer approved in South Korea
By IPP Bureau - November 17, 2021
Launching in 2022, its availability will be expanded to the global market
U.S FDA authorises EaseVRx, immersive virtual reality for pain relief
By IPP Bureau - November 17, 2021
EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference
Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards
By IPP Bureau - November 16, 2021
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
Pre-diabetes is a much more serious issue in India: Fitterfly
By IPP Bureau - November 16, 2021
Two out of three people under the age of 40 are at risk of prediabetes
Biocon Biologics partners with RSSDI to expand insulin access
By IPP Bureau - November 16, 2021
BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children
Vicco Labs moves to sustainable Platina tube packaging
By IPP Bureau - November 16, 2021
Platina 250, 300 & 350 Lamitubes have been recognized by the Association of Plastic Recyclers (APR), USA as meeting or exceeding the strict APR HDPE critical guidance criteria on recyclability
Govt allows post-mortem procedure to be performed after sunset
By IPP Bureau - November 16, 2021
The union health ministry notifies the protocol and this move will also help in organ donation
